Saindhav revolves around costliest injection

Saindhav revolves around costliest injection. According to reliable sources, the highly-anticipated film ‘Saindhav,’ featuring Venkatesh, is rumored to revolve around Zolgensma, recognized as the world's most expensive drug. This injectable treatment, priced at over Rs 17 crore, is sourced from the United States of America and stands as a one-time gene therapy for spinal muscular atrophy, as revealed by an insider. The film is poised not only to shed light on the exorbitant cost of such medications but also to unveil the questionable practices within the pharmaceutical industry and its unethical ties with corporate hospitals.

In a departure from his usual fun-centric roles, Venkatesh is expected to champion a social cause in ‘Saindhav,’ presenting audiences with a new dimension to his on-screen persona. Taking on the powerful forces of corporate criminals and their accomplices, the actor's character aims to instigate change and make medical care more accessible to the common man.

The film is anticipated to navigate through the complexities of family dynamics, emphasizing the relationships between the father, wife, and daughter, before delving into the sinister world of the medical mafia. This unique plot choice sets 'Saindhav' apart as no Telugu film has explored this topic before, promising a captivating experience for Venkatesh's fans and the wider audience.

Helmed by the young and promising director Shailesh, known for his previous investigative cop dramas like ‘HIT 1’ and ‘HIT 2,’ the film is reported to have exceeded its budget, making it the costliest venture in the director's burgeoning career. Despite the financial investment, ‘Saindhav’ is poised to offer a gripping narrative that tackles crucial societal issues, reaffirming Venkatesh's commitment to diverse and socially relevant storytelling.